文献速递慢性肾脏病肾移植

成人CKD及肾移植后疫苗接种预防感染综述

Vaccinations to Prevent Infections in Adult Individuals With CKD and After Kidney Transplantation: A Review.
PubMed 文献 · Am J Kidney Dis · 2026-02-25

综述指出CKD尤其透析患者感染住院和死亡风险高,流感、肺炎球菌肺炎和呼吸道合胞病毒感染可通过疫苗预防,但CKD免疫减弱及免疫抑制治疗降低疫苗血清反应性,需考虑疫苗选择、剂量和接种程序;肾移植后免疫抑制进一步削弱应答,但疫苗仍可在相当数量患者中有效,移植受体一般不应接种活疫苗,通常推荐移植后6个月接种,但数据显示流感疫苗最早移植后4周接种不增加风险,遗漏推荐疫苗是错失预防相关感染并发症的机会。

要点

  • CKD尤其透析患者感染住院和死亡风险高,流感、肺炎球菌和呼吸道合胞病毒疫苗可预防。
  • CKD免疫减弱及免疫抑制治疗降低疫苗血清反应性,需个体化选择疫苗、剂量和程序。
  • 移植受体一般禁活疫苗,通常推荐移植后6个月接种,流感疫苗最早4周接种不增加风险。

核心结论

  • CKD及肾移植患者感染风险高且疫苗可预防,但免疫减弱降低疫苗应答,仍需按公共卫生建议广泛接种以减少疾病负担。

研究设计与样本

  • 本文为综述,总结CKD及肾移植后疫苗接种预防感染的现有证据与推荐。

主要发现

  • CKD尤其透析患者感染导致住院、疾病和死亡风险高,流感、肺炎球菌肺炎和呼吸道合胞病毒感染占典型感染并发症的显著比例且可疫苗预防。
  • CKD免疫系统减弱降低疫苗效力,部分患者接受免疫抑制药物,疫苗血清反应性降低需考虑疫苗选择、剂量和程序。
  • 肾移植后免疫抑制进一步损害疫苗应答,但疫苗仍可在相当数量患者中有效并提供保护。
  • 移植受体一般不应接种活疫苗以防疫苗诱导并发症,通常推荐移植后6个月免疫抑制较弱时接种,但可能与季节性疫苗冲突而常被遗漏。
  • 数据显示至少流感疫苗最早可在移植后4周接种且不增加额外风险。

关键数值与推荐

  • CKD患者疫苗一般安全,应按照公共卫生建议广泛使用以减少疾病。
  • 移植受体一般不应接种活疫苗。
  • 疫苗接种通常推荐在移植后6个月,此时免疫抑制较早期数月弱。
  • 至少流感疫苗最早可在移植后4周接种而不增加额外风险。

临床怎么用

  • 对CKD尤其透析患者应广泛按公共卫生建议接种流感、肺炎球菌和呼吸道合胞病毒疫苗以减少感染并发症。
  • 选择疫苗、剂量和程序时需考虑CKD免疫减弱及免疫抑制药物导致的血清反应性降低。
  • 肾移植受体避免活疫苗,通常移植后6个月接种,但流感疫苗可考虑最早移植后4周接种。
  • 避免遗漏CKD或移植后患者推荐的疫苗接种,以免错失预防相关感染并发症的机会。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Patients with chronic kidney disease (CKD), especially those undergoing dialysis, are at high risk of infections that lead to hospitalizations, morbidity, and mortality. Influenza, pneumococcal pneumonia, and respiratory syncytial virus infections account for a significant proportion of typical infectious complications and are preventable by vaccination. The immune system is weakened in CKD, reducing vaccination efficacy. Additionally, some patients with CKD receive immunosuppressive medications. The reduced seroreactivity to various vaccines must be considered when selecting vaccines, vaccine doses, and schedules for patients with CKD. Vaccinations are generally safe in CKD and should be widely used in accordance with public health recommendations to reduce morbidity. Immunosuppression after kidney transplant further impairs vaccination responses. Nevertheless, vaccinations can still be effective and provide protection in a relevant number of patients. Patients who have received transplants should generally not receive live vaccines because of the risk of vaccine-induced complications. Vaccination is usually recommended 6 months after transplant, when immunosuppression is less intense than in the early months. This approach may conflict with seasonal vaccinations, which are often omitted. Data show that at least the influenza vaccination can be administered as early as 4 weeks after transplant without additional risk. In all patients with CKD or posttransplant status, omitting recommended vaccinations is a missed opportunity to prevent relevant infectious complications.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Girndt M. Vaccinations to Prevent Infections in Adult Individuals With CKD and After Kidney Transplantation: A Review. Am J Kidney Dis. 2026. PMID: 41759616. doi:10.1053/j.ajkd.2025.10.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。